Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belotecan in Recurrent or Progressive Cervical Cancer
NCT00430144Phase 2Completed
- Start
- Jan 2007
- Primary completion
- Aug 2009
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of belotecan in Cervical Cancer (CC). Primary endpoint: Overall Response Rate. Started Jan 2007; status: completed.
02
Drugs
belotecan
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00430144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430144.